Cogent Biosciences
COGT
COGT
179 hedge funds and large institutions have $973M invested in Cogent Biosciences in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 36 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.79% more ownership
Funds ownership: 117.25% → 119.04% (+1.8%)
4% less funds holding
Funds holding: 186 → 179 (-7)
17% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 35
Holders
179
Holding in Top 10
9
Calls
$20.5M
Puts
$6.52M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$8.01M | |
| 3 | +$7.7M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.74M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$4.96M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$9.8M | |
| 3 | -$7.95M | |
| 4 |
SG Americas Securities
New York
|
-$5.68M |
| 5 |
VA
VR Adviser
New York
|
-$5.15M |